Collaborating? Here’s how to avoid a web of IP issues
22 August 2025
Commercial collaboration can create unbeatable opportunities for innovation and securing return on investment.
Read on
Patents
Expert evidence blows up detonator patent litigation
25 July 2025
In a long, but intricately reasoned first instance judgment, Australia’s Federal Court has ruled on the validity and infringement of patents relating to wireless detonators.
Read on
Branched meanings: Lexicography of ‘branched alkyl’ decides Moderna’s COVID-19 vaccine patent dispute
1 July 2025
The United States Court of Appeals for the Federal Circuit (CAFC) recently decided that Moderna’s mRNA-based COVID-19 vaccine, SPIKEVAX®, did not infringe Alnylam’s patents because the cationic lipid used in the vaccine, SM-102, was not a cationic lipid with a ‘branched alkyl’ group.[1] The case turned on the proper construction of ‘branched alkyl’.
Read on
Gene-ius at stake: who really cracked CRISPR in plants and animals?
3 June 2025
Many of our readers will have first heard of CRISPR-Cas9 a number of years ago.
Read on
One year on: the Treaty, WIPO, Traditional Knowledge, and patents
15 May 2025
Imagine an organisation obtaining patent protection over a formulation derived from Kakadu plum, while the First Nations community whose Knowledge guided the discovery receives neither recognition nor benefit.
Read on
Stop! In the name of interlocutory injunctions: lessons from 2024
17 March 2025
Interlocutory injunctions can be a critical tool to help protect intellectual property rights by restraining alleged infringement while a substantive infringement proceeding is run.
Read on
Substance over form(ulations)? An update on patent term extensions
18 February 2025
Two recent Federal Court decisions illustrate that term extensions are available for a broad range of patents, including formulation patents.
Read on
The patentability of software in the US
12 November 2024
We are lucky to share with you insights from our New York patent experts Charles Wizenfeld, Michael S.
Read on
Proposed modifications to the regulation of gene technology in Australia
4 November 2024
The Department of Health and Aged Care is proposing the first major amendments to the Gene Technology Act 2000 (Cth) (the Act) since its commencement.
Read on
The mRNA patent wars: lessons for businesses & organisations who rely on patent rights
28 October 2024
Two weeks ago, GlaxoSmithKline (GSK) filed proceedings against the makers of the COVID-19 SPIKEVAX® vaccine, Moderna, Inc in the US Federal District Court in Delaware alleging that Moderna has infringed its patents relating to messenger RNA (mRNA) technology.
Read on
Load More Posts